Making muscle: skeletal myogenesis in vivo and in vitro
- PMID: 28634270
- DOI: 10.1242/dev.151035
Making muscle: skeletal myogenesis in vivo and in vitro
Abstract
Skeletal muscle is the largest tissue in the body and loss of its function or its regenerative properties results in debilitating musculoskeletal disorders. Understanding the mechanisms that drive skeletal muscle formation will not only help to unravel the molecular basis of skeletal muscle diseases, but also provide a roadmap for recapitulating skeletal myogenesis in vitro from pluripotent stem cells (PSCs). PSCs have become an important tool for probing developmental questions, while differentiated cell types allow the development of novel therapeutic strategies. In this Review, we provide a comprehensive overview of skeletal myogenesis from the earliest premyogenic progenitor stage to terminally differentiated myofibers, and discuss how this knowledge has been applied to differentiate PSCs into muscle fibers and their progenitors in vitro.
Keywords: Dermomyotome; Embryonic stem cells; Muscle differentiation; Muscular dystrophy; Paraxial mesoderm; Pluripotent stem cells; Skeletal myogenesis; Somite; iPS cells.
© 2017. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsO.P. and J.C. are co-founders and share-holders of Anagenesis Biotechnologies, a start-up company specialized in the production of muscle cells in vitro for cell therapy and drug screening.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources